The gastroenteritis testing market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to reliance on conventional immunoassay and culture-based methods, limited availability of advanced molecular diagnostics, increasing prevalence of gastrointestinal infections, rising hospital and clinic diagnostic capabilities, expansion of research institutes in infectious disease studies.
The gastroenteritis testing market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in molecular diagnostic technologies, growing demand for rapid point-of-care testing, increasing funding for infectious disease research, rising adoption of integrated laboratory information systems, expansion of gastroenteritis testing in emerging markets. Major trends in the forecast period include increasing demand for rapid and accurate gastroenteritis diagnostics, rising adoption of molecular diagnostic testing methods, expansion of viral, bacterial, and parasitic testing panels, growth in point-of-care testing and hospital-based diagnostics, enhanced focus on epidemiological surveillance and outbreak management.
The rising incidence of bacterial infections is increasingly supporting the expansion of the gastroenteritis testing market going forward. Bacterial infections are becoming more prevalent due to increased antibiotic resistance, higher population density, and expanded global travel, which accelerates the spread of resistant pathogens. Gastroenteritis testing plays a critical role in identifying bacterial causes of symptoms such as diarrhea and vomiting, enabling appropriate treatment and helping prevent further transmission. For example, in 2024, according to GOV.UK, a UK-based government organization, cases of bacteraemia caused by antibiotic-resistant bacteria increased by 9.3% from 18,740 cases in 2023 to 20,484 cases in 2024. Consequently, the rising incidence of bacterial infections is reinforcing demand within the gastroenteritis testing market.
Leading companies operating in the gastroenteritis testing market are developing innovative solutions, such as molecular gastrointestinal panels, to deliver high sensitivity and specificity in pathogen detection. Molecular gastrointestinal tests use techniques such as polymerase chain reaction (PCR) to identify genetic material from pathogens in gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAstat-Dx Gastrointestinal Panel 2. This panel enables rapid detection of up to 16 bacterial, viral, and parasitic pathogens using real-time PCR, significantly reducing turnaround time compared with traditional culture-based diagnostic methods.
In December 2024, the Indian Council of Medical Research (ICMR), an India-based national medical research organization, entered into a partnership with Molbio Diagnostics Pvt. Ltd. to expand global access to advanced multiplex RT-PCR technology for detecting enteric viruses responsible for childhood gastroenteritis. This collaboration leverages Molbio’s commercialization expertise and global diagnostic distribution network to improve accessibility. Molbio Diagnostics Pvt. Ltd. is an India-based provider of portable and rapid molecular diagnostic solutions designed to support timely disease detection across diverse healthcare environments.
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation.
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastroenteritis testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the gastroenteritis testing market by increasing the cost of imported diagnostic reagents, molecular testing kits, and laboratory equipment. Segments such as molecular diagnostic testing and advanced immunoassay kits are most affected, with regions like Asia-Pacific, including China and India, facing significant import duties. This has led to higher operational costs and potential delays in testing kit availability. On the positive side, tariffs encourage local production of diagnostic kits and equipment, fostering innovation and boosting domestic manufacturing capabilities.
The gastroenteritis testing market research report is one of a series of new reports that provides gastroenteritis testing market statistics, including gastroenteritis testing industry global market size, regional shares, competitors with a gastroenteritis testing market share, detailed gastroenteritis testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastroenteritis testing industry. This gastroenteritis testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastroenteritis testing includes diagnostic methods used to identify the cause of inflammation in the stomach and intestines. Since gastroenteritis can result from viruses, bacteria, or parasites, these tests help determine the cause and guide appropriate treatment such as antibiotics, antivirals, or supportive care.
The major types of gastroenteritis testing include viral gastrointestinal infections, bacterial gastrointestinal infections, and parasitic gastrointestinal infections. Viral gastrointestinal infections are conditions caused by viruses affecting the stomach and intestines, resulting in symptoms such as diarrhea, vomiting, and abdominal discomfort. Testing is conducted for bacterial, viral, and parasitic strains using methods such as immunoassay testing, conventional testing, and molecular diagnostic testing. These tests are utilized by end users including hospitals, clinics or medical centers, research institutions, and diagnostic laboratories.
The gastroenteritis testing market consists of revenues earned by entities by providing services such as culture testing, imaging services, hydration assessment, and consultation and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroenteritis testing market also includes sales of stool collection kits, rapid test kits, endoscopic equipment, and culture media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The gastroenteritis testing market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in molecular diagnostic technologies, growing demand for rapid point-of-care testing, increasing funding for infectious disease research, rising adoption of integrated laboratory information systems, expansion of gastroenteritis testing in emerging markets. Major trends in the forecast period include increasing demand for rapid and accurate gastroenteritis diagnostics, rising adoption of molecular diagnostic testing methods, expansion of viral, bacterial, and parasitic testing panels, growth in point-of-care testing and hospital-based diagnostics, enhanced focus on epidemiological surveillance and outbreak management.
The rising incidence of bacterial infections is increasingly supporting the expansion of the gastroenteritis testing market going forward. Bacterial infections are becoming more prevalent due to increased antibiotic resistance, higher population density, and expanded global travel, which accelerates the spread of resistant pathogens. Gastroenteritis testing plays a critical role in identifying bacterial causes of symptoms such as diarrhea and vomiting, enabling appropriate treatment and helping prevent further transmission. For example, in 2024, according to GOV.UK, a UK-based government organization, cases of bacteraemia caused by antibiotic-resistant bacteria increased by 9.3% from 18,740 cases in 2023 to 20,484 cases in 2024. Consequently, the rising incidence of bacterial infections is reinforcing demand within the gastroenteritis testing market.
Leading companies operating in the gastroenteritis testing market are developing innovative solutions, such as molecular gastrointestinal panels, to deliver high sensitivity and specificity in pathogen detection. Molecular gastrointestinal tests use techniques such as polymerase chain reaction (PCR) to identify genetic material from pathogens in gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAstat-Dx Gastrointestinal Panel 2. This panel enables rapid detection of up to 16 bacterial, viral, and parasitic pathogens using real-time PCR, significantly reducing turnaround time compared with traditional culture-based diagnostic methods.
In December 2024, the Indian Council of Medical Research (ICMR), an India-based national medical research organization, entered into a partnership with Molbio Diagnostics Pvt. Ltd. to expand global access to advanced multiplex RT-PCR technology for detecting enteric viruses responsible for childhood gastroenteritis. This collaboration leverages Molbio’s commercialization expertise and global diagnostic distribution network to improve accessibility. Molbio Diagnostics Pvt. Ltd. is an India-based provider of portable and rapid molecular diagnostic solutions designed to support timely disease detection across diverse healthcare environments.
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation.
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastroenteritis testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the gastroenteritis testing market by increasing the cost of imported diagnostic reagents, molecular testing kits, and laboratory equipment. Segments such as molecular diagnostic testing and advanced immunoassay kits are most affected, with regions like Asia-Pacific, including China and India, facing significant import duties. This has led to higher operational costs and potential delays in testing kit availability. On the positive side, tariffs encourage local production of diagnostic kits and equipment, fostering innovation and boosting domestic manufacturing capabilities.
The gastroenteritis testing market research report is one of a series of new reports that provides gastroenteritis testing market statistics, including gastroenteritis testing industry global market size, regional shares, competitors with a gastroenteritis testing market share, detailed gastroenteritis testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastroenteritis testing industry. This gastroenteritis testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastroenteritis testing includes diagnostic methods used to identify the cause of inflammation in the stomach and intestines. Since gastroenteritis can result from viruses, bacteria, or parasites, these tests help determine the cause and guide appropriate treatment such as antibiotics, antivirals, or supportive care.
The major types of gastroenteritis testing include viral gastrointestinal infections, bacterial gastrointestinal infections, and parasitic gastrointestinal infections. Viral gastrointestinal infections are conditions caused by viruses affecting the stomach and intestines, resulting in symptoms such as diarrhea, vomiting, and abdominal discomfort. Testing is conducted for bacterial, viral, and parasitic strains using methods such as immunoassay testing, conventional testing, and molecular diagnostic testing. These tests are utilized by end users including hospitals, clinics or medical centers, research institutions, and diagnostic laboratories.
The gastroenteritis testing market consists of revenues earned by entities by providing services such as culture testing, imaging services, hydration assessment, and consultation and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroenteritis testing market also includes sales of stool collection kits, rapid test kits, endoscopic equipment, and culture media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Gastroenteritis Testing Market Characteristics
3. Gastroenteritis Testing Market Supply Chain Analysis
4. Global Gastroenteritis Testing Market Trends and Strategies
5. Gastroenteritis Testing Market Analysis of End Use Industries
7. Global Gastroenteritis Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Gastroenteritis Testing Total Addressable Market (TAM) Analysis for the Market
9. Gastroenteritis Testing Market Segmentation
10. Gastroenteritis Testing Market Regional and Country Analysis
11. Asia-Pacific Gastroenteritis Testing Market
12. China Gastroenteritis Testing Market
13. India Gastroenteritis Testing Market
14. Japan Gastroenteritis Testing Market
15. Australia Gastroenteritis Testing Market
16. Indonesia Gastroenteritis Testing Market
17. South Korea Gastroenteritis Testing Market
18. Taiwan Gastroenteritis Testing Market
19. South East Asia Gastroenteritis Testing Market
20. Western Europe Gastroenteritis Testing Market
21. UK Gastroenteritis Testing Market
22. Germany Gastroenteritis Testing Market
23. France Gastroenteritis Testing Market
24. Italy Gastroenteritis Testing Market
25. Spain Gastroenteritis Testing Market
26. Eastern Europe Gastroenteritis Testing Market
27. Russia Gastroenteritis Testing Market
28. North America Gastroenteritis Testing Market
29. USA Gastroenteritis Testing Market
30. Canada Gastroenteritis Testing Market
31. South America Gastroenteritis Testing Market
32. Brazil Gastroenteritis Testing Market
33. Middle East Gastroenteritis Testing Market
34. Africa Gastroenteritis Testing Market
36. Gastroenteritis Testing Market Competitive Landscape and Company Profiles
37. Gastroenteritis Testing Market Other Major and Innovative Companies
40. Gastroenteritis Testing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Gastroenteritis Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses gastroenteritis testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gastroenteritis testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastroenteritis testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Viral Gastrointestinal Infections; Bacterial Gastrointestinal Infections; Parasitic Gastrointestinal Infections2) By Disease Strains: Bacterial Strains; Viral Strains; Parasitic Strains
3) By Testing Methods: Immunoassay Testing; Conventional Testing; Molecular Diagnostic Testing
4) By End-User: Hospitals; Clinics Or Medical Centers; Research Institutes; Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus; Rotavirus; Astrovirus; Adenovirus; Sapovirus2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli); Salmonella; Campylobacter; Shigella; Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia; Entamoeba histolytica; Cryptosporidium; Trichinella; Strongyloides stercoralis
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Abbott Diagnostics; Laboratory Corporation of America Holdings; Thermo Fisher Scientific Inc.; Eurofins Scientific SE; Hologic Inc.; Becton Dickinson and Company; bioMérieux SA; Quest Diagnostics Incorporated; DiaSorin S.p.A.; Bio-Rad Laboratories Inc.; Randox Laboratories Ltd.; ARUP Laboratories; Meridian Bioscience Inc.; MedGenome; Trinity Biotech plc; Savyon Diagnostics Ltd.; Coris BioConcept; Aster Clinical Research & Diagnostic Centre Pvt. Ltd.; Alimetrix Inc.; Luminex Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Gastroenteritis Testing market report include:- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Abbott Diagnostics
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- Eurofins Scientific SE
- Hologic Inc.
- Becton Dickinson and Company
- bioMérieux SA
- Quest Diagnostics Incorporated
- DiaSorin S.p.A.
- Bio-Rad Laboratories Inc.
- Randox Laboratories Ltd.
- ARUP Laboratories
- Meridian Bioscience Inc.
- MedGenome
- Trinity Biotech plc
- Savyon Diagnostics Ltd.
- Coris BioConcept
- Aster Clinical Research & Diagnostic Centre Pvt. Ltd.
- Alimetrix Inc.
- Luminex Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.44 Billion |
| Forecasted Market Value ( USD | $ 5.55 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
